table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2032)
1.4.2 East Asia Market States and Outlook (2023-2032)
1.4.3 Europe Market States and Outlook (2023-2032)
1.4.4 South Asia Market States and Outlook (2023-2032)
1.4.5 Southeast Asia Market States and Outlook (2023-2032)
1.4.6 Middle East Market States and Outlook (2023-2032)
1.4.7 Africa Market States and Outlook (2023-2032)
1.4.8 Oceania Market States and Outlook (2023-2032)
1.4.9 South America Market States and Outlook (2023-2032)
1.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Analysis from 2023 to 2032
1.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Analysis from 2023 to 2032 by Consumption Volume
1.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Analysis from 2023 to 2032 by Value
1.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Trends Analysis from 2023 to 2032
1.6 COVID-19 Outbreak: Diagnostic Radiopharmaceuticals & Contrast Media Industry Impact
Chapter 2 Global Diagnostic Radiopharmaceuticals & Contrast Media Competition by Types, Applications, and Top Regions and Countries
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media (Volume and Value) by Type
2.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Market Share by Type (2017-2022)
2.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Type (2017-2022)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media (Volume and Value) by Application
2.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Market Share by Application (2017-2022)
2.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Application (2017-2022)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media (Volume and Value) by Regions
2.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Regions (2017-2022)
4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
4.10 South America Diagnostic Radiopharmaceuticals & Contrast Media Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
5.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
5.1.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
5.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
5.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
5.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
5.4.1 United States Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
5.4.2 Canada Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
5.4.3 Mexico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 6 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
6.1 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
6.1.1 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
6.2 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
6.3 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
6.4 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
6.4.1 China Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
6.4.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
6.4.3 South Korea Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 7 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
7.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
7.4.1 Germany Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.2 UK Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.3 France Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.4 Italy Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.5 Russia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.6 Spain Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.7 Netherlands Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.8 Switzerland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
7.4.9 Poland Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 8 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
8.1 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
8.1.1 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
8.2 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
8.3 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
8.4 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
8.4.1 India Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
8.4.2 Pakistan Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
9.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
9.1.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
9.2 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
9.3 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
9.4 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
9.4.1 Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.2 Thailand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.3 Singapore Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.4 Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.5 Philippines Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.6 Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
9.4.7 Myanmar Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 10 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
10.1 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
10.1.1 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
10.2 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
10.3 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
10.4 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
10.4.1 Turkey Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.3 Iran Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.5 Israel Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.6 Iraq Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.7 Qatar Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.8 Kuwait Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
10.4.9 Oman Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 11 Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
11.1 Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
11.1.1 Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
11.2 Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
11.3 Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
11.4 Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
11.4.1 Nigeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
11.4.2 South Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
11.4.3 Egypt Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
11.4.4 Algeria Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
11.4.5 Morocco Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 12 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
12.1 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
12.2 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
12.3 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
12.4 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption by Top Countries
12.4.1 Australia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
12.4.2 New Zealand Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 13 South America Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis
13.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption and Value Analysis
13.1.1 South America Diagnostic Radiopharmaceuticals & Contrast Media Market Under COVID-19
13.2 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Types
13.3 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Structure by Application
13.4 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume by Major Countries
13.4.1 Brazil Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.2 Argentina Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.3 Columbia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.4 Chile Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.5 Venezuela Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.6 Peru Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
13.4.8 Ecuador Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Diagnostic Radiopharmaceuticals & Contrast Media Business
14.1 Amag Pharmaceuticals
14.1.1 Amag Pharmaceuticals Company Profile
14.1.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bayer Healthcare
14.2.1 Bayer Healthcare Company Profile
14.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bracco Imaging
14.3.1 Bracco Imaging Company Profile
14.3.2 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Daiichi Sankyo
14.4.1 Daiichi Sankyo Company Profile
14.4.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 GE Healthcare
14.5.1 GE Healthcare Company Profile
14.5.2 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Guerbet
14.6.1 Guerbet Company Profile
14.6.2 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Lantheus
14.7.1 Lantheus Company Profile
14.7.2 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Mallinckrodt
14.8.1 Mallinckrodt Company Profile
14.8.2 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Medtronic
14.9.1 Medtronic Company Profile
14.9.2 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Nordion
14.10.1 Nordion Company Profile
14.10.2 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Specification
14.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast (2023-2032)
15.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Price Forecast (2023-2032)
15.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume and Growth Rate Forecast (2023-2032)
15.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Value and Growth Rate Forecast (2023-2032)
15.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Value and Growth Rate Forecast by Region (2023-2032)
15.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume and Growth Rate Forecast by Regions (2023-2032)
15.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Value and Growth Rate Forecast by Regions (2023-2032)
15.2.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.4 East Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.6 South Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.7 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.8 Middle East Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.9 Africa Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.10 Oceania Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.2.11 South America Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Growth Rate Forecast (2023-2032)
15.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume, Revenue and Price Forecast by Type (2023-2032)
15.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Forecast by Type (2023-2032)
15.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2023-2032)
15.3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Type (2023-2032)
15.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Consumption Volume Forecast by Application (2023-2032)
15.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
